Searched for
REZUROCK
Sanofi launches Rezurock against chronic Graft-versus-host disease in IndiaSanofi Healthcare India has obtained marketing authorization for Rezurock, a drug for treating Chronic graft versus host disease (cGVHD), a...- Sanofi looks for accelerated growth in India; plans fast-tracking of product pipelineSanofi, a leading French pharmaceutical company, aims to expand its presence in the Indian market by introducing new drugs, enhancing local...
- Sanofi plans to launch 1 or 2 products in India every yearSanofi prioritizes the Indian market, focusing on diabetes, consumer health, and innovation. With a strategic shift under Hrosz's leadershi...
- Load More